Zomedica Pharmaceuticals Corp. Opens the Market

TORONTO, May 3, 2016 /CNW/ - Gerald Solensky, Jr., Chief Executive Officer, Zomedica Pharmaceuticals Corp. (ZOM) joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company to open the market. Zomedica is a veterinary pharmaceutical company based in Ann Arbor, Michigan, targeting health and wellness solutions for companion animals (canine, feline and equine) through an approach that focuses on the needs of clinical veterinarians. Zomedica Pharmaceuticals Corp. commenced trading on TSX Venture Exchange on May 2, 2016.

SOURCE Toronto Stock Exchange

Image with caption: "Gerald Solensky, Jr., Chief Executive Officer, Zomedica Pharmaceuticals Corp. (ZOM) joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company to open the market. Zomedica is a veterinary pharmaceutical company based in Ann Arbor, Michigan, targeting health and wellness solutions for companion animals (canine, feline and equine) through an approach that focuses on the needs of clinical veterinarians. Zomedica Pharmaceuticals Corp. commenced trading on TSX Venture Exchange on May 2, 2016. (CNW Group/TMX Group Limited) (CNW Group/Toronto Stock Exchange)". Image available at: http://photos.newswire.ca/images/download/20160503_C9163_PHOTO_EN_44739.jpg


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890